VACCITECH (SP.ADR)/1 (F:2AB) — Market Cap & Net Worth

$20.62 Million USD · €17.64 Million EUR · Rank #24944

Market Cap & Net Worth: VACCITECH (SP.ADR)/1 (2AB)

VACCITECH (SP.ADR)/1 (F:2AB) has a market capitalization of $20.62 Million (€17.64 Million) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #24944 globally and #2154 in its home market, demonstrating a 10.26% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying VACCITECH (SP.ADR)/1's stock price €0.51 by its total outstanding shares 40830353 (40.83 Million).

VACCITECH (SP.ADR)/1 Market Cap History: 2021 to 2026

VACCITECH (SP.ADR)/1's market capitalization history from 2021 to 2026. Data shows change from $427.23 Million to $23.10 Million (-46.18% CAGR).

VACCITECH (SP.ADR)/1 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how VACCITECH (SP.ADR)/1's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of 2AB by Market Capitalization

Companies near VACCITECH (SP.ADR)/1 in the global market cap rankings as of May 4, 2026.

Key companies related to VACCITECH (SP.ADR)/1 by market ranking:

Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#223	Vertex Pharmaceuticals Inc	NASDAQ:VRTX	$107.56 Billion	$423.92
#367	Regeneron Pharmaceuticals Inc	NASDAQ:REGN	$72.88 Billion	$701.42
#517	UCB SA	BR:UCB	$51.45 Billion	€231.20
#568	argenx NV ADR	NASDAQ:ARGX	$45.97 Billion	$787.95

VACCITECH (SP.ADR)/1 Historical Marketcap From 2021 to 2026

Between 2021 and today, VACCITECH (SP.ADR)/1's market cap moved from $427.23 Million to $ 23.10 Million, with a yearly change of -46.18%.

Year	Market Cap	Change (%)
2026	€23.10 Million	-13.57%
2025	€26.73 Million	-42.56%
2024	€46.54 Million	-69.91%
2023	€154.66 Million	+51.40%
2022	€102.15 Million	-76.09%
2021	€427.23 Million	--

End of Day Market Cap According to Different Sources

On Apr 24th, 2026 the market cap of VACCITECH (SP.ADR)/1 was reported to be:

Source	Market Cap
Yahoo Finance	$20.62 Million USD
MoneyControl	$20.62 Million USD
MarketWatch	$20.62 Million USD
marketcap.company	$20.62 Million USD
Reuters	$20.62 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About VACCITECH (SP.ADR)/1

F:2AB Germany Biotechnology

Market Cap

$24.11 Million

€20.62 Million EUR

Market Cap Rank

#24944 Global

#2154 in Germany

Share Price

€0.51

Change (1 day)

+5.65%

52-Week Range

€0.45 - €1.54

All Time High

€14.00